1. Name of the medicinal product
MabThera 1400 mg solution for subcutaneous injection
2. Qualitative and quantitative composition
Each mL contains 120 mg of rituximab.
Each vial contains 1400 mg/11.7 mL rituximab.
Rituximab is a genetically engineered chimeric mouse/human monoclonal antibody representing a glycosylated immunoglobulin with human IgG1 constant regions and murine light-chain and heavy-chain variable region sequences. The antibody is produced by mammalian (Chin |
